Clinical Trials Directory

Trials / Completed

CompletedNCT05266703

Defining the Serum Ferritin Concentration in Kenyan Women at Which the Body Senses Iron Depletion and Begins to Upregulate Iron Absorption

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
1,000 (actual)
Sponsor
Swiss Federal Institute of Technology · Academic / Other
Sex
Female
Age
18 Years – 28 Years
Healthy volunteers
Accepted

Summary

The serum or plasma ferritin concentration (referred to hereafter as ferritin) is the most widely used indicator to detect iron deficiency and a low ferritin indicates depleted iron stores. However, the threshold ferritin that defines iron deficiency remains unclear and diagnostic ferritin cutoffs from expert groups vary widely. Our study aim is to define the ferritin in Kenyan young women at which the body senses iron depletion and begins to upregulate iron absorption from the diet; this approach could provide a functionally defined threshold of iron deficiency in Sub-Saharan African women.

Conditions

Interventions

TypeNameDescription
OTHERIsotopically labelled iron sulfate 15mgtest drink: water containing isotopic iron solution with vitamin C

Timeline

Start date
2022-02-18
Primary completion
2023-06-30
Completion
2023-06-30
First posted
2022-03-04
Last updated
2024-01-25

Locations

1 site across 1 country: Kenya

Source: ClinicalTrials.gov record NCT05266703. Inclusion in this directory is not an endorsement.